XML 32 R36.htm IDEA: XBRL DOCUMENT
v2.4.0.8

LICENSE AGREEMENTS (Details Textual) (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended |  | 1 Months Ended | 6 Months Ended | 1 Months Ended |  | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Dec. 30, 2012 | Dec. 31, 2013 | Jun. 23, 2014 Ligand [Member] | Jun. 30, 2014 Ligand [Member] | Jun. 23, 2014 Ligand [Member] Maximum [Member] | Jun. 23, 2014 Ligand [Member] Minimum [Member] | Jun. 23, 2014 Opus Point Partners, Llc [Member] | Jun. 23, 2014 Opus Point Partners, Llc [Member] Maximum [Member] | Jun. 30, 2014 Research and Development Expense [Member] | Jun. 30, 2014 Research and Development Expense [Member]
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
License revenue | $ 38,095 | $ 38,095 | $ 76,190 | $ 76,190 |  |  |  |  |  |  |  |  |  |
Deferred Revenue | 1,752,381 |  | 1,752,381 |  |  | 1,829,000 |  |  |  |  |  |  |  |
Additional Amount Receivable On Achievement Of Pre Specified Milestones |  |  | 5,000,000,000 |  |  |  |  |  |  |  |  |  |  |
Income taxes |  |  |  |  | 330,000 |  |  |  |  |  |  |  |  |
Business Acquisition Purchase Agreement Period Description |  |  | license revenue on a straight-line basis over the life of the agreement, which is through the expiration of the last licensed patent right or 15 years after the first commercial sale of a product in such country, unless the agreement is earlier terminated |  |  |  |  |  |  |  |  |  |  |
Proceeds from Fees Received |  |  |  |  | 2,000,000 |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Issued for Services |  |  |  |  |  |  |  | 125,000 |  |  |  |  |  |
Non Cash Stock Expense | 1,211,250 | 0 | 1,211,250 | 0 |  |  |  |  |  |  |  |  | 1,211,250 | 1,211,250
Maximum Potential Payments Payable |  |  |  |  |  |  | 207,000,000 |  |  |  |  |  |  |
Royalty payment Effective Percentage |  |  |  |  |  |  |  |  | 9.50% | 6.00% | 1.00% |  |  |
Maximum sales for royalty expense |  |  |  |  |  |  |  |  | 1,000,000,000 |  |  | 1,000,000,000 |  |
Accounts and Other Receivables, Net, Current | $ 152,000 |  | $ 152,000 |  |  |  |  |  |  |  |  |  |  |

X
- Definition Reflects potential milestone payments to be received upon achievement of pre-specified milestone. + References No definition available. + Details
Name: | tgtx_AdditionalAmountReceivableOnAchievementOfPreSpecifiedMilestones
Namespace Prefix: | tgtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | tgtx_LicenseAgreementLineItems
Namespace Prefix: | tgtx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the maximum potential milestone payments upon the achievement of specific clinical regulatory and commercial milestione events + References No definition available. + Details
Name: | tgtx_MaximumPotentialPaymentsPayable
Namespace Prefix: | tgtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the maximum sales for royalty expense. + References No definition available. + Details
Name: | tgtx_MaximumSalesForRoyaltyExpense
Namespace Prefix: | tgtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate expense related to the issuance of stock in connection with in-licensing agreements during the reporting period. + References No definition available. + Details
Name: | tgtx_NonCashStockExpense
Namespace Prefix: | tgtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the Royalty payment Effective Percentage. + References No definition available. + Details
Name: | tgtx_RoyaltyPaymentEffectivePercentage
Namespace Prefix: | tgtx_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. + References No definition available. + Details
Name: | us-gaap_AccountsAndOtherReceivablesNetCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition In the year of acquisition, if the assets of the acquired institution exceed 10 percent of the consolidated assets at the end of the most recent period, describes the amounts of discounts and premiums for fair market value adjustments, methods of amortization (accretion), and estimated remaining lives. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 + Details
Name: | us-gaap_DeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_LicensesRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received for fees during the current period. This element excludes cash proceeds from license fees. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration